Eugene Goldenberg

Director

(212) 981-6902
egoldenberg@cainbrothers.com
Download vCard

Cain Brothers Experience

Eugene Goldenberg is a Director in the Firm’s Corporate M&A Advisory practice. Mr. Goldenberg joined Cain Brothers in 2012 with over 6 years’ healthcare services equity research experience covering many of the same sector verticals where he now utilizes his advisory and deal execution capabilities. Mr. Goldenberg’s recent notable transactions include the sale of Alacare Home Health & Hospice to Encompass Health (NYSE: EHC) for $217.5 million; acquisition of CIVITAS Solutions (NYSE: CIVI) by Centerbridge Partners for ~$1.4 billion; sale of Optimal Health Services to Bristol Hospice, sale of Sciformix to Covance, drug development subsidiary of LabCorp (NYSE: LH); sale of Jordan Health Services to Kelso & Company and Blue Wolf Capital Partners; acquisition of Sarnova by Patricia Industries, private equity subsidiary of publicly traded Swedish industrial holding company, Investor AB (OM:INVE A) for $903 million; sale of St. Croix Hospice to the Vistria Group; sale of TMG Health (a subsidiary of HCSC) to Cognizant Technology Solutions (NASDAQ: CTSH); sale of New Century Hospice to Curo Health Services; and the sale of Salveo Specialty Pharmacy to Catamaran (NASDAQ: CTRX).

Prior Experience

Prior to joining Cain Brothers, Mr. Goldenberg was a Senior Equity Research Analyst at BB&T Capital Markets, where he focused on various healthcare services verticals, including Post-Acute Care (Home Health, Hospice, Skilled Nursing Facilities, and Long-Term Acute Care Hospitals), as well as Pharmacy Benefit Managers, Specialty Supplies Distribution, Community-Based Services, Specialty Pharmacy, Home Infusion, Healthcare IT, and Wellness / Disease Management.

Mr. Goldenberg’s prior experience also includes working within Morgan Stanley’s Controller Financial Reporting group.

Education

Mr. Goldenberg graduated with high honors from Rutgers University with a BS in Finance and a minor in Art History.